Spelling Pneumocystis jirovecii.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report.BMC infectious diseases · 2019
   Article
2. A targeted delivery strategy for the development of potent trypanocides.Chemical communications (Cambridge, England) · 2017
   Article
3. Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients.World journal of transplantation · 2016
   Review
4. The Utility of Blood and Bone Marrow Films and Trephine Biopsy Sections in the Diagnosis of Parasitic Infections.Mediterranean journal of hematology and infectious diseases · 2015
   Review
5. Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.Rheumatology (Oxford, England) · 2012
   Review

Corrections and comments

• Comment on
  A new name (Pneumocystis jiroveci) for Pneumocystis from humans.2002

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as